Shengyong Yang
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 09, 2025
ADAR1-mediated RNA editing in breast cancer: molecular mechanisms and therapeutic implications.Si-Yu Chen, Si-Ying Chen, Shu Yang
|Dec 23, 2022
Icariin Treatment Rescues Diabetes Induced Bone Loss via Scavenging ROS and Activating Primary Cilia/Gli2/Osteocalcin Signaling Pathway.Jie Liu, Qingfeng Cheng, Xiangmei Wu
|Sep 09, 2022
RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.Yi Li, Ning-Xi Wang, Chuan Yin
|Nov 01, 2021
MsrB1 Promotes Proliferation and Invasion of Colorectal Cancer Cells via GSK-3β/β-catenin Signaling Axis.Xiao-Yu Chen, Sheng-Yong Yang, Xiao-Jie Ruan
|Sep 10, 2020
8-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway.Hong-Yue Ding, Wan-Yong Yang, Li-Hong Zhang
|May 31, 2018
DNA Damage-Response Pathway Heterogeneity of Human Lung Cancer A549 and H1299 Cells Determines Sensitivity to 8-Chloro-Adenosine.Sheng-Yong Yang, Yi Li, Guo-Shun An
Pageof 1
